| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/25/2000 | US6054291 Culturing cells to produce and recover human growth hormone |
| 04/25/2000 | US6054290 Human vesicle binding protein |
| 04/25/2000 | US6054289 Polynucleotides encoding human ADA2 |
| 04/25/2000 | US6054288 Drug delivery to mammalian cells; obtaining cells from a mammal, transfecting cells with vector epressing therapy agent, culturing transfected cells, introducing transfected cells into a mammal |
| 04/25/2000 | US6054284 Immunoreagents reactive with a conserved epitope of human immunodeficiency virus type I (HIV-1) GP120 and methods of use |
| 04/25/2000 | US6054283 Antibodies against human herpesvirus-6(HHV-6) and method of use |
| 04/25/2000 | US6054273 Inhibitors of alternative alleles of genes as a basis for cancer therapeutic agents |
| 04/25/2000 | US6054269 Polynucleotides and their use for detecting enterococci and streptococci bacterial strains |
| 04/25/2000 | US6054265 Screening assays for compounds that inhibit membrane fusion-associated events |
| 04/25/2000 | US6054264 Methods of typing hepatitis C virus and reagents for use therein |
| 04/25/2000 | US6054163 Used as a food preservative |
| 04/25/2000 | US6054135 Compounds and methods for the detection and prevention of T. cruzi infection |
| 04/25/2000 | US6054134 An immunogen which binds specifically to phosphatidylethanolamine, gangliotriaosylceramide and gangliotetraosylceramide; protecting susceptible mammals from diseases caused by bacterial influenzae pathogens |
| 04/25/2000 | US6054132 A purified toxin in diagnostic testing for detecting peptic ulceration and gastric malignancy, and as a vaccine for providing immunologic protection against bacterial infection |
| 04/25/2000 | US6054131 Vaccine composition for herpes simplex virus and method of using |
| 04/25/2000 | US6054130 Non-splicing variants of gp350/220 |
| 04/25/2000 | US6054126 A synthetic polypeptide containing the conformational epitope recognized by monoclonal antibody mab 17-82 for neutralizing antibodies in an avian host; stimulating an immune response against infectious bursal disease virus in poultry |
| 04/25/2000 | US6054125 Purified mite allergen |
| 04/25/2000 | US6054124 A milk or a polypeptide subfraction of milk obtained from the allergen treated host, for preventing or alleviating allergic reactions |
| 04/25/2000 | US6054122 A foamable fibrin matrix comprising fibrinogen or metabolite and an foaming agent which causes fibrinogen to foam during application of fibrinogen to wounded tissue |
| 04/25/2000 | CA2155762C Protein modification method |
| 04/25/2000 | CA2155728C Regulated transcription of targeted genes and other biological events |
| 04/25/2000 | CA2106079C Pegylation of polypeptides |
| 04/25/2000 | CA2098021C Composition used as a therapeutic agent against chronic viral hepatic diseases |
| 04/25/2000 | CA2019803C Feline interferon and process for production thereof |
| 04/25/2000 | CA1340977C Scavenger receptor protein and antibody thereto |
| 04/25/2000 | CA1340976C Fibroblast growth factor antagonists |
| 04/25/2000 | CA1340974C Plant universal stress-inducible regulatory element |
| 04/25/2000 | CA1340972C Follistatin and method of purifying same |
| 04/25/2000 | CA1340971C Metalloproteinase inhibitor sequence recombinant vector system for using the same and recombinant-dna method for the manufacture of same |
| 04/25/2000 | CA1340970C Lipase from gastric mucosa |
| 04/22/2000 | CA2285749A1 Novel proteins from actinobacillus pleuropneumoniae |
| 04/20/2000 | WO2000022439A2 Method and substances for diagnosis and therapy of sepsis and sepsis-like systemic infections |
| 04/20/2000 | WO2000022438A1 Assay for disease related conformation of a protein |
| 04/20/2000 | WO2000022430A2 Neisseria genomic sequences and methods of their use |
| 04/20/2000 | WO2000022166A2 Genes for assessing cardiovascular status and compositions for use thereof |
| 04/20/2000 | WO2000022151A1 Parvovirus vectors and their use |
| 04/20/2000 | WO2000022146A1 EXPRESSION AND SECRETION OF icIL-1 RECEPTOR ANTAGONIST TYPE II |
| 04/20/2000 | WO2000022142A2 Cell signaling polypeptides and nucleic acids |
| 04/20/2000 | WO2000022137A2 Selectively replicating viral vectors |
| 04/20/2000 | WO2000022136A2 Recombinant e1a deleted adenoviral vectors |
| 04/20/2000 | WO2000022135A1 Helicobacter pylori vaccine |
| 04/20/2000 | WO2000022134A2 Test kit for diagnosis of borrelia infection and novel borrelia antigens for the development of vaccines |
| 04/20/2000 | WO2000022133A1 Fungal genes required for normal growth and development |
| 04/20/2000 | WO2000022132A2 Nucleic acids that control reproductive development in plants |
| 04/20/2000 | WO2000022131A2 Non-endogenous, constitutively activated human g protein-coupled receptors |
| 04/20/2000 | WO2000022130A2 Metastatic breast and colon cancer regulated genes |
| 04/20/2000 | WO2000022129A1 Non-endogenous, constitutively activated human g protein-coupled receptors |
| 04/20/2000 | WO2000022128A1 Protein conjugates containing multimers of green fluorescent protein |
| 04/20/2000 | WO2000022127A1 Compositions and methods based upon p35, an isoform of p53 |
| 04/20/2000 | WO2000022126A1 Follistatin-related protein zfsta2 |
| 04/20/2000 | WO2000022125A2 6-protein-coupled receptor-like proteins, polynucleotides encoded by them, and methods of using same |
| 04/20/2000 | WO2000022124A2 Methods and compositions to induce antitumor response |
| 04/20/2000 | WO2000022123A1 Novel protein war-1 and gene thereof |
| 04/20/2000 | WO2000022122A2 Genes, proteins and biallelic markers related to central nervous system disease |
| 04/20/2000 | WO2000022121A2 Ion channels, in particular vanilloid receptor-like (vr-l) receptor |
| 04/20/2000 | WO2000022120A1 (mbp1) polypeptides capable of interacting with oncogenic mutants of the p53 protein |
| 04/20/2000 | WO2000022119A1 METHOD FOR OBTAINING ACTIVE β-NGF |
| 04/20/2000 | WO2000022118A2 Non-desensitizing ampa-receptors |
| 04/20/2000 | WO2000022117A1 Tumor protein |
| 04/20/2000 | WO2000022116A1 Human mdg1 gene (cbfawb10) |
| 04/20/2000 | WO2000022115A2 Assays for identifying functional alterations in the p53 tumor suppressor |
| 04/20/2000 | WO2000022112A1 Stabilized bioactive peptides and methods of identification, synthesis and use |
| 04/20/2000 | WO2000022110A2 Targeted proteolysis by recruitment to ubiquitin protein ligases |
| 04/20/2000 | WO2000022109A1 Molecular markers for determining a patient's risk of developing agranulocytosis |
| 04/20/2000 | WO2000022107A1 Method for amplifying foreign gene |
| 04/20/2000 | WO2000022093A2 Novel interferon stimulated and repressed genes |
| 04/20/2000 | WO2000022092A2 Materials and methods for the modification of plant cell wall polysaccharides |
| 04/20/2000 | WO2000022001A2 A potassium channel of the erg family |
| 04/20/2000 | WO2000022000A1 Methods for the production of antibodies to specific regions of cyclosporine and cyclosporine metabolites |
| 04/20/2000 | WO2000021999A1 Novel g protein-coupled receptors |
| 04/20/2000 | WO2000021998A1 Bone morphogenetic protein antagonist based on the mature protein |
| 04/20/2000 | WO2000021997A1 D-1 like dopamine receptor activity modifying protein |
| 04/20/2000 | WO2000021996A2 Methods and compositions for inhibiting neoplastic cell growth |
| 04/20/2000 | WO2000021995A1 Treatment of inflammatory disease |
| 04/20/2000 | WO2000021994A1 Human ptd011 gene (tpaahe09) |
| 04/20/2000 | WO2000021993A1 Human ptd010 gene (tpaaag12) |
| 04/20/2000 | WO2000021992A1 A human fk506 binding protein (fkbp) |
| 04/20/2000 | WO2000021991A1 SECRETED EXPRESSED SEQUENCE TAGS (sESTs) |
| 04/20/2000 | WO2000021990A1 SECRETED EXPRESSED SEQUENCE TAGS (sESTs) |
| 04/20/2000 | WO2000021989A1 Decorin binding proteins dbp a and b and genes encoding them |
| 04/20/2000 | WO2000021988A2 Human ankyrin family protein |
| 04/20/2000 | WO2000021987A2 A method of identifying modulators of cell surface membrane receptors useful in the treatment of disease |
| 04/20/2000 | WO2000021986A2 Matrix-remodeling genes |
| 04/20/2000 | WO2000021985A2 Genes encoding olfactory receptors and biallelic markers thereof |
| 04/20/2000 | WO2000021984A2 Nucleic acids encoding human cide-b protein and polymorphic markers thereof |
| 04/20/2000 | WO2000021983A2 Tuberculosis vaccine and diagnostic reagents based on antigens from the mycobacterium tuberculosis cell |
| 04/20/2000 | WO2000021978A2 Laminin 5, 13 and 14 and uses thereof |
| 04/20/2000 | WO2000021976A1 Bone morphogenic protein-induced genes and polypeptides, and their use in diagnostic and therapeutic methods |
| 04/20/2000 | WO2000021574A2 Site-directed dual pegylation of proteins |
| 04/20/2000 | WO2000021569A2 Macromolecular active substance conjugates and a method for the production thereof |
| 04/20/2000 | WO2000021554A1 Preventives or remedies for cachexia |
| 04/20/2000 | WO2000021553A2 Method of regulating smn gene expression |
| 04/20/2000 | WO2000021551A1 Isolated peptides which bind to hla-b35 molecules |
| 04/20/2000 | WO2000021548A2 Angiogenically effective unit dose of fgf and method of administering |
| 04/20/2000 | WO2000021366A1 Method for preserving a hemoglobin blood substitute |
| 04/20/2000 | WO2000021362A1 VIABLE PrP (PRION PROTEIN) TRANSGENIC ANIMALS AND METHODS OF USE |
| 04/20/2000 | WO2000006605A9 Heterominibodies |
| 04/20/2000 | WO2000004162A3 Genes encoding sulfate assimilation proteins |
| 04/20/2000 | WO2000004155A3 Compositions and methods for enhancing disease resistance in plants |